DIHYDROISOCHINOLINYLDERIVATE

Patent europeic · EP4263522 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4263522
Numer da la dumonda
EP21840512
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-12-2021
Publitgà
25-10-2023
Concedì
02-10-2024
La protecziun finescha il pli tard
15-12-2041
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07D 401/14 (2006.01)
A61K 31/454 (2006.01)
A61P 25/00 (2006.01)
Prioritad
EP 20215251 18.12.2020
Dumonda PCT
PCT/EP2021/086131 16.12.2021
Publicaziun PCT
WO2022/129303 23.06.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 13-08-2025

    Midada

    Published in Swissreg on 13.08.2025

  3. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  4. 03-10-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.10.2024

Partidas

Possessur

UCB Biopharma SRL

60, Allée de la Recherche, 1070 Brussels, BE

Inventur

HALL, Adrian

1070 Brussels, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.